Arrang JM - Search Results

1

Constitutive activity of the histamine H3 receptor.

Arrang JM, Morisset S, Gbahou F. Arrang JM, et al. Trends Pharmacol Sci. 2007 Jul;28(7):350-7. doi: 10.1016/j.tips.2007.05.002. Epub 2007 Jun 15. Trends Pharmacol Sci. 2007. PMID: 17573125 Review.

2

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Apelt J, et al. Among authors: arrang jm. J Med Chem. 2002 Feb 28;45(5):1128-41. doi: 10.1021/jm0110845. J Med Chem. 2002. PMID: 11855993

3

Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.

Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W. Grassmann S, et al. Among authors: arrang jm. Eur J Pharm Sci. 2002 May;15(4):367-78. doi: 10.1016/s0928-0987(02)00024-6. Eur J Pharm Sci. 2002. PMID: 11988398

4

Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Pillot C, Ortiz J, Héron A, Ridray S, Schwartz JC, Arrang JM. Pillot C, et al. Among authors: arrang jm. J Neurosci. 2002 Aug 15;22(16):7272-80. doi: 10.1523/JNEUROSCI.22-16-07272.2002. J Neurosci. 2002. PMID: 12177222 Free PMC article.

5

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: arrang jm. J Med Chem. 2002 Aug 29;45(18):4000-10. doi: 10.1021/jm020910m. J Med Chem. 2002. PMID: 12190321

6

Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, modulates the effects of methamphetamine on neuropeptide mRNA expression in rat striatum.

Pillot C, Héron A, Schwartz JC, Arrang JM. Pillot C, et al. Among authors: arrang jm. Eur J Neurosci. 2003 Jan;17(2):307-14. doi: 10.1046/j.1460-9568.2003.02422.x. Eur J Neurosci. 2003. PMID: 12542667

7

Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.

Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: arrang jm. J Med Chem. 2003 Apr 10;46(8):1523-30. doi: 10.1021/jm021084k. J Med Chem. 2003. PMID: 12672253

8

Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.

Grassmann S, Apelt J, Sippl W, Ligneau X, Pertz HH, Zhao YH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Grassmann S, et al. Among authors: arrang jm. Bioorg Med Chem. 2003 May 15;11(10):2163-74. doi: 10.1016/s0968-0896(03)00120-2. Bioorg Med Chem. 2003. PMID: 12713826

9

Protean agonism at histamine H3 receptors in vitro and in vivo.

Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin JS, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM. Gbahou F, et al. Among authors: arrang jm. Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11086-91. doi: 10.1073/pnas.1932276100. Epub 2003 Sep 5. Proc Natl Acad Sci U S A. 2003. PMID: 12960366 Free PMC article.

10

Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: arrang jm. Bioorg Med Chem. 2004 May 15;12(10):2727-36. doi: 10.1016/j.bmc.2004.03.009. Bioorg Med Chem. 2004. PMID: 15110854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results